Search Results | PharmaJet

GOLDEN, Colo. — Feb. 20, 2018 — PharmaJet®, the maker of innovative, needle-free injection technology, today announced a global license agreement with Genexine, a leading biotherapeutics company headquartered in South Korea, for the development and commercialization of DNA vaccines for human applications using the PharmaJet needle-free injection systems.

News

Tags: DNA, Nucleic Acid, Other, Tropis

February 2, 2018

Vaccibody Expands Human Clinical Trial of HPV Vaccine

GOLDEN, Colo. — Feb. 6, 2018 — PharmaJet, the maker of innovative, needle-free injection technology, today announced that Vaccibody AS is expanding their human clinical trial (phase IIa) for the study of a vaccine to treat HPV disease using the PharmaJet Stratis® needle-free injection system.

News

Tags: DNA, HPV, Nucleic Acid, Stratis

January 26, 2018

PharmaJet touts needle-free tech for polio vaccine administration

PharmaJet touted results today from a study evaluating its needle-free injection technology as a way to administer the poliovirus vaccine.

Press Coverage

Tags: Polio, Tropis

Study shows superiority of PharmaJet Needle-free Injector for poliovirus vaccine administration

GOLDEN, Colo. — Jan. 23, 2018 — PharmaJet® Inc., the maker of innovative, needle-free injection technology, announced that a study was published in Heliyon Journal showing PharmaJet needle-free injection is superior to needle and syringe for fractional dose poliovirus vaccine campaigns.

News

Tags: Polio, Tropis

January 9, 2018

Zika Virus vaccine shows significantly higher immune response with Needle-free delivery

GOLDEN, Colo. — Jan. 9, 2018 — PharmaJet, the maker of innovative, needle-free injection technology announced that a recently published study in The Lancet demonstrated that delivery of a Zika virus vaccine with the PharmaJet Stratis^® Needle-free Jet injector produced a significantly higher immune response, as compared with administration via needle and syringe.

News

Tags: DNA, Nucleic Acid, Stratis, Zika

January 4, 2018

Success of mRNA Rabies Vaccine Human Study linked to Needle-free Injection

GOLDEN, Colo. – Dec. 5, 2017 – PharmaJet® Inc., the maker of needle-free injection technology, announced today that the first ever human clinical study of an mRNA rabies vaccine successfully showed immunogenicity when administered with their needle-free injection devices.

News

Tags: mRNA, Nucleic Acid, Rabies, Stratis, Tropis, Tropis/Stratis

November 7, 2017

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial

2017 Alberer, M

Clinical Studies

Tags: Improved Performance, Other Viruses, Phase 1, Rabies, RNA, Stratis, Tropis, Tropis/Stratis

September 23, 2017

Feasibility of conducting intradermal vaccination campaign with inactivated poliovirus vaccine using Tropis intradermal needle free injection system, Karachi, Pakistan

2017 Yousafzai, MT

Clinical Studies

Tags: Inactivated, Polio, Tropis

September 18, 2017

InnoSTARS Hot, New U.S. Medical Tech Winner Exciting Shot to Arm

InnoSTARS crowned a hot, new medical technology winner delivering an exciting shot to the arm of the technology landscape with its breakthrough innovation gaining international attention.

Press Coverage

Tags: Stratis, Tropis, Tropis/Stratis

August 18, 2017

Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial

2017 Jackson, LA

Clinical Studies

Tags: Live Attenuated, Other Viruses, Phase 2, Pox, Stratis

March 23, 2017

PharmaJet® partners with Serum Institute to Launch Needle-Free MMR Vaccine

GOLDEN, Colo. — Mar. 7, 2017 — PharmaJet, the maker of innovative, needle-free injection technology, announced its partnership with Serum Institute of India, the world’s largest vaccine manufacturer, is commercializing needle-free delivery of the MMR vaccine using the Stratis^® 0.5mL needle-free injection system.

News

Tags: MMR, Stratis

February 28, 2017

NIH Zika Vaccine Initial Trial Results Encouraging

Golden, Co. — Jan. 4 , 2017 — PharmaJet, the maker of innovative, needle-free injection technology, was featured on a CBS 60 Minutes segment concerning the National Institutes of Health DNA vaccine clinical trial for the Zika virus.